t. Appl., WO2007146718, Also published as:CA2653657A1, CN101466674A, CN102167678A, CN102167678B, CN102174008A, CN103086944A, EP2032533A2, EP2032533B1, EP2032533B8, EP2394991A1, US8536346, US20090306405, US20120010418, WO2007146718A3. Filing date:Jun 7, 2007
Izumo, Seigo and Shetty, Suraj Shivappa. Preparation of cinnamic acid N-hydroxy amides as histone deacetylase inhibitors for the treatment of pathologic cardiac hypertrophy and heart failure. PCT Int. Appl., WO2007021682, 22 Feb 2007
Revill, N. Mealy, N. Serradell, J. Bolos, E. Rosa, Drugs Future, 2007, 32(4), 315.
Acemoglu, Murat; Bajwa, Joginder S.; Karpinski, Piotr; Papoutsakis, Dimitris; Slade, Joel; Stowasser, Frank. Preparation of polymorphs of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide.PCT Int. Appl. (2007), WO2007146716 A2, 20071221
Bajwa, Joginder S.; Parker, David John; Slade, Joel. Preparation of salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide. PCT Int. Appl. (2007), WO2007146717 A2, 20071221.
Acemoglu, Murat; Bajwa, Joginder S.; Karpinski, Piotr; Papoutsakis, Dimitris; Slade, Joel; Stowasser, Frank. Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide. PCT Int. Appl. (2007), WO2007146715 A1 20071221.
Slade, Joel et al. Optimization and Scale-Up of the Grandberg Synthesis of 2-Methyltryptamine. Organic Process Research & Development, 11(4), 721-725; 2007
Bair, Kenneth Walter et al. Preparation of hydroxamic acids as deacetylase inhibitors. PCT Int. Appl., WO2002022577, 21 Mar 2002
